Tailoring mind-body therapies to individual needs: patients' program preference and psychological traits as moderators of the effects of mindfulness-based cancer recovery and supportive-expressive therapy in distressed breast cancer survivors

Journal of the National Cancer Institute. Monographs
Linda E CarlsonMichael Speca

Abstract

Mindfulness-based cancer recovery (MBCR) and supportive-expressive therapy (SET) are well-validated psycho-oncological interventions, and we have previously reported health benefits of both programs. However, little is known about patients' characteristics or program preferences that may influence outcomes. Therefore, this study examined moderators of the effects of MBCR and SET on psychological well-being among breast cancer survivors. A multi-site randomized controlled trial was conducted between 2007 and 2012 in two Canadian cities (Calgary and Vancouver). A total of 271 distressed stage I-III breast cancer survivors were randomized into MBCR, SET or a 1-day stress management seminar (SMS). Baseline measures of moderator variables included program preference, personality traits, emotional suppression, and repressive coping. Outcome measures of mood, stress symptoms, quality of life, spiritual well-being, post-traumatic growth, social support, and salivary cortisol were measured pre- and post intervention. Hierarchical regression analyses were used to assess moderator effects on outcomes. The most preferred program was MBCR (55%). Those who were randomized to their preference improved more over time on quality of life and spi...Continue Reading

References

Jan 1, 1991·Social Science & Medicine·C D Sherbourne, A L Stewart
Jul 1, 1987·Journal of Personality and Social Psychology·D M WegnerT L White
Jan 1, 1983·Journal of Psychosomatic Research·M Watson, S Greer
Jan 1, 1994·Psychoneuroendocrinology·C Kirschbaum, D H Hellhammer
Jul 1, 1996·Journal of Traumatic Stress·R G Tedeschi, L G Calhoun
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J BradyG Shiomoto
May 15, 2002·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Amy H PetermanDavid Cella
Aug 17, 2002·Journal of Consulting and Clinical Psychology·Janine Giese-DavisDavid Spiegel
Sep 22, 2005·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Patricia LinSusan C Hedrick
Feb 14, 2007·Journal of Consulting and Clinical Psychology·Brian M IacovielloJacques P Barber
Nov 16, 2007·International Journal of Behavioral Medicine·Linda E Carlson, Bejoy Cherian Thomas
Nov 4, 2008·BMJ : British Medical Journal·UNKNOWN Preference Collaborative Review Group
Apr 23, 2010·Journal of the National Comprehensive Cancer Network : JNCCN·Alex J Mitchell
Oct 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Linda E CarlsonBarry D Bultz
Aug 7, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Linda E CarlsonMichael Speca
Oct 22, 2013·Patient Preference and Adherence·Sophia E Winter, Jacques P Barber

❮ Previous
Next ❯

Citations

Feb 4, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Christina TomeiBrittany Mutsaers
Mar 11, 2016·Annals of the New York Academy of Sciences·Linda E Carlson
Mar 10, 2015·Journal of the National Cancer Institute. Monographs·Jun J Mao, Lorenzo Cohen
Aug 24, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julienne E Bower
Sep 20, 2017·British Journal of Cancer·Charlotte GrégoireMarie-Elisabeth Faymonville
Feb 10, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sheila N GarlandJun J Mao
Jun 6, 2018·Journal of Psychosocial Oncology·Myriam RudazJoseph G Grzywacz
Mar 4, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Christina TomeiCheryl Harris
Jun 30, 2018·European Journal of Pain : EJP·E ScalaP-Y Rodondi
Apr 2, 2019·Journal of Psychosocial Oncology·Brittany D KorotkinPaul R Duberstein
Nov 28, 2019·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·C Graham FordAnita Y Kinney
Nov 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne K ChambersDavid P Smith
Dec 16, 2016·Disability and Rehabilitation·Jo NijsNiamh Moloney
Apr 28, 2021·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Devesh OberoiLinda E Carlson
Apr 28, 2021·Journal of Psychosocial Oncology·Katie DarabosJennifer S Ford
Jul 6, 2021·Current Opinion in Psychiatry·Aliza A Panjwani, Madeline Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.